Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
[The specific features of the course of chronic viral hepatitis concurrent with chronic opisthorchiasis].
- E. I. Beloborodova, M. I. Rachkovskiĭ, +8 authors R. F. Abdrashitov
- Medicine
- Klinicheskaia meditsina
- 2004
A hundred and one patients with chronic viral hepatitis (CVH) in the phase of replication were examined. Group 1 comprised 53 patients with CVH in combination with chronic opisthorchiasis. Group 2 (a… Expand
[Combined treatment with reaferon and iodantipirin in patients with chronic viral hepatitides B and C].
- E. I. Beloborodova, M. A. Vnushinskaia, +5 authors D. Kuz'menko
- Medicine
- Terapevticheskii arkhiv
- 2005
AIM
To examine clinical efficacy of combined therapy with reaferon and iodantipirin in patients with chronic hepatitis B and C of moderate activity.
MATERIAL AND METHODS
100 patients with confirmed… Expand
[Lochein - a novel hepatoprotective drug].
- E. I. Beloborodova, A. Saratikov, A. I. Vengerovskii, A. A. Shalovaĭ
- Medicine
- Klinicheskaia meditsina
- 2000
A trial of a novel hepatoprotective plant drug lochein (Salsola extract) developed in Russia was performed in 110 patients with a verified chronic hepatitis of viral (73 patients) or alcohol (36… Expand
[Clinical response to combined treatment with reaferon and iodantipirin in patients with chronic HCV- and HBV-infection].
- E. I. Beloborodova, M. A. Vnushinskaia, M. I. Rachkovskiĭ, A. A. Shalovaĭ, O. A. Timoshchuk, N. V. Khudoleĭ
- Medicine
- Klinicheskaia meditsina
- 2002
The treatment was given to 100 patients with chronic virus hepatitis of moderate activity and chronicity stage I. Of them, 50 patients received reaferon (3 IU 3 times a week) in combination with… Expand